Bio Green Med Solution, Inc.
BGMS· Nasdaq
BGMSBio Green Med Solution, Inc.
Released Nov 12, 2024, after the close
10-Q filed Nov 12, 2024, 43 days after period end · 0001558370-24-015349
| Metric | Q3 2024 | Q3 2023 | Q3 2022 | Q3 2021 |
|---|---|---|---|---|
| Revenue | $10.00K | $16.00K | $0.00 | $0.00 |
| Net Income | -$1.96M | -$6.03M | -$5.10M | -$4.76M |
| EPS Diluted |
Bio Green Med Solution, Inc. · CIK 1130166 · Engraved from SEC EDGAR
| -$43.80 |
| — |
| -$0.42 |
| -$0.51 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
